Operating Grant: Bringing Rare Disease Gene Therapies to Clinical Trial Readiness
Canadian Institutes of Health Research (CIHR)
This funding opportunity will support research to bridge the current gap between model organisms/systems and clinical trials for RD drugs in Canada, ultimately increasing the capacity to bring gene therapies to clinic.
The maximum amount per grant is $1,137,500 for up to four years.
The LOI is not required to be submitted to ORS prior to submission for the LOI deadline.
Anticipated Notice of Decision: June 4, 2024
Funding Start Date: April 1, 2024
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 20-Sep-2023 |
Application | 02-Feb-2024 4:30 pm CST | 13-Feb-2024 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.